Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $233.47. The company's market cap stands at 563.36B, with a P/E ratio of 27.19 and a dividend yield of 2.23%.
On 2026-06-17, Johnson & Johnson(JNJ) stock traded between a low of $230.70 and a high of $235.46. Shares are currently priced at $233.47, which is +1.2% above the low and -0.8% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 8.55M, against a daily average of 7.73M.
During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.
JNJ News
The Dividend Growth Path That Turns $60,000 a Year Into $125,000 By Drew Wood Published Jun 17, 4:42PM EDT Quick Read A starting yield of 3 to 4 percent growi...
Johnson & Johnson (JNJ) CEO Joaquin Duato says his company has no plans to venture into the fast-growing market for GLP-1 obesity drugs and will instead focus o...
Johnson & Johnson (JNJ) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that co...
Analyst ratings
68%
of 25 ratingsMore JNJ News
...
How to Build $3,000 a Month in Dividend Income to Cover the Average Social Security Check By Drew Wood Published Jun 16, 2:49PM EDT Quick Read Generating $36,...
Key Points The State Street Health Care Select Sector SPDR ETF offers a significantly lower expense ratio of 0.08% compared to 0.38% for the iShares U.S. Healt...
RBC Capital analyst Trung Huynh tells investors in a research note that CMS on Friday proposed making the Medicare Drug Price Negotiation Program permanent begi...
Earlier this month, Johnson & Johnson reported late-stage trial results showing its bispecific antibody TALVEY, combined with DARZALEX FASPRO with or without po...
Pharma giant Johnson & Johnson (JNJ) has found a new target for its four-year $55 billion U.S. manufacturing expansion plan launched in March 2025. The company...
Johnson & Johnson announced an investment of more than $1B in Jacksonville, Florida to strengthen its Vision operations by scaling U.S.-based manufacturing, pac...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.